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Aging augments postischemic apoptosis via incomplete mechanisms. Our previous animal study suggests that in addition to
proapoptotic eﬀects, lncRNAs also exert antiapoptotic eﬀects in cardiomyocytes. However, whether this unexpected
phenomenon exists in humans is unknown. In the present study, we investigated the relationship between aging and apoptosis
regulation in human blood samples and conﬁrmed their role by utilizing the cardiomyocyte lines (AC16 cells). Human blood
samples were collected from 20 pairs of older adult and young volunteers. Age-diﬀerent apoptotic regulatory lncRNAs and
miRNAs were identiﬁed by microarray and bioinformatics analysis. The results indicated that lncRNA (NONHSAT069381 and
NONHSAT140844) and miRNA (hsa-miR-124-5p and hsa-miR-6507-5p) were increased in aging human blood, conﬁrmed by
both bioinformatics analysis and polymerase chain reaction (PCR). Overexpression of NONHSAT069381 in AC16 cells
increased caspase-3 levels and increased cardiomyocyte apoptotic cell death (determined by TUNEL staining and caspase
activity assays) after hypoxia/reoxygenation (H/R), while overexpression of NONHSAT140844 increased X-chromosome-linked
inhibitor of apoptosis protein (XIAP) content and decreased the myocardial apoptotic cell death. Furthermore, luciferase
reporter assay revealed that hsa-miR-124-5p might be a mediator between NONHSAT069381 and mCASP3 and hsa-miR-65075p might be a mediator between NONHSAT140844 and mXIAP. Overexpression of hsa-miR-124-5p decreased caspase-3 levels
and overexpression of hsa-miR-6507-5p decreased XIAP content in AC16 cells. We have found evidence that lncRNAs are
important regulatory molecules in aging-mediated eﬀects upon apoptosis. More interestingly, besides apoptosis-promoting
eﬀects, aging also inhibits myocardial apoptosis after H/R. This phenomenon also exists in the human cardiomyocyte line.

1. Introduction
Age is one of the most important risk factors for a wide range
of diseases. Unfortunately, the overall increasing age of the
world’s population is accompanied by the rise in diseases
including cardiovascular and neurodegenerative diseases
and cancer and immune disorders [1]. Given the recent lifestyle and diet changes in China, coronary heart disease
(CHD) has been one of the leading causes of mortality and
its incidence continues to climb annually. Due to technological advances in emergency percutaneous coronary intervention (PCI), early myocardial infarction (MI) mortality has
decreased dramatically, but a signiﬁcant number of MI

patients develop heart failure after 5 years post-PCI [2, 3].
Interestingly, nearly all of these individuals are older adult
patients.
Aging is an independent risk factor for ischemia-related
heart failure, which promotes the continuous decline of cardiac function after ischemia. Apoptosis plays a vital role in
heart failure development. In 2012, through a combination
of small-scale clinical trials and animal experiments, we demonstrated aging may promote cardiac apoptosis, a signiﬁcant
cause of ischemia-induced heart failure [4]. Studies from
other labs also reported that aging signiﬁcantly promotes
apoptosis [5, 6]. However, to date, the precise mechanisms
linking aging to myocardial apoptosis remain unknown.
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Our previous study indicated that aging augmented
in vivo reactive oxygen species (ROS) and reactive nitrogen
species (RNS) levels after ischemia/reperfusion (I/R) [7].
Liu et al. indicated that Omi/HtrA2 mRNA and protein
expression in the myocardium of aging rats aggravated I/R
injury by inducing apoptosis of myocardial cells [8]. This
may be the mechanism by which aging promotes cardiomyocyte apoptosis. However, the above mechanism might not be
“the core” of apoptosis-regulated eﬀects of aging.
Long noncoding RNAs (lncRNAs) range from 200 bp to
several kilobases in length and do not encode any protein
[9]. Due to poor evolutionary conservation relative to the
protein-coding regions of the genome, lncRNAs were once
considered transcriptional noise or junk and have not been
well studied historically. However, more in-depth research
unveiled the important roles of lncRNAs in transcriptional,
posttranscriptional RNA processing, translation, DNA methylation, and chromatin architecture [9–12]. Using mouse
hearts, our previous study demonstrated that lncRNAs
played vital roles in hypoxia-induced myocardial apoptosis
[13]. More interestingly, our results indicated that in addition
to apoptosis-promoting eﬀects, lncRNAs also inhibited myocardial apoptosis by activating apoptosis-inhibiting factors.
With mouse data, it can only be postulated that lncRNAs
regulate apoptosis regulatory eﬀects in vivo. However, the
precise roles that lncRNAs in aging-related cardiomyocyte
apoptosis play in humans remain uncertain. In our current
study, we aim to (1) examine the eﬀects of aging-related
lncRNA on apoptosis in human cardiomyocyte lines, (2)
analyze whether lncRNA has a bidirectional regulatory eﬀect
on cardiomyocyte apoptosis, and (3) explore the exact mechanism related to lncRNA aﬀecting cardiomyocyte apoptosis.

2. Materials and Methods
2.1. Human Blood Sample Collection. We enrolled 40 healthy
men (20 older adults and 20 young). All members of the
older adult group met the following inclusion criteria: (1)
above 65 years of age; (2) absence of any signiﬁcant clinical
symptoms (chest pain, chest tightness, dizziness, and nausea); (3) absence of diagnosed chronic diseases (for example,
coronary heart disease, cerebrovascular disease, respiratory
diseases, dyslipidemia, and diabetes); (4) absence of any previous surgeries (interventional therapies or surgical operation); (5) absence of any signiﬁcant family medical history;
(6) absence of tobacco and alcohol use; (7) blood pressure
ðBPÞ ≤ 150/90 mmHg at the time of enrollment; (8) absence
of chronic medication use (aspirin, steroid hormone, and
immunosuppression drugs); and (9) absence of autoimmune
diseases (for example, rheumatic heart disease or vasculitis).
Inclusion criteria for the group of young men were the same
as the older adult group, except that these men were all younger than 35 years old. Exclusion criteria for any patient in this
study included major infection within the last 2 weeks.
All human sample harvests were carried out in accordance with the Declaration of Helsinki. The study protocol
was approved by the institutional ethics committee in Beijing
An Zhen Hospital, Capital Medical University. After full
disclosure of the study’s purpose, nature, and inherent risk
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of participation, all subjects gave written informed consent
prior to study inclusion.
2.2. lncRNA/miRNA Microarray. For Aﬀymetrix microarray
proﬁling, total RNA was isolated from 40 blood samples
(20 older adult and young pairs) by TRIzol reagent (Invitrogen, Carlsbad, Canada), digested by DNase treatment, and
puriﬁed with a RNeasy Mini Kit (Qiagen, Hilden, Germany),
per manufacturer’s protocol. The amount and quality of
RNA were determined by a UV-Vis Spectrophotometer
(Thermo, NanoDrop 2000, USA) at 260 nm absorbance.
The lncRNA and miRNA expression proﬁling was measured
by GeneChip Human Clariom™ D Assay (Aﬀymetrix GeneChip, Santa Clara, CA, USA), containing 134,700 gene-level
probe sets. The microarray analysis was performed by Aﬀymetrix Expression Console Software (version 4.0). Raw data
(CEL ﬁles) were normalized at the transcript level using a
robust multiarray average method (RMA workﬂow). Median
summarizations of transcript expressions were calculated.
Gene-level data were then ﬁltered to include only those probe
sets present in the “core” metaprobe list representing RefSeq
genes.
2.3. Bioinformatics Analysis
2.3.1. Signiﬁcant Diﬀerential Gene Analysis. The random variance model (RVM) t-test was used to identify diﬀerentially
expressed genes for the older adult and young groups. This
model has more power than standard tests to detect large
changes in expression, without increasing the rate of false
positives. After using signiﬁcant and false discovery rate
(FDR) analyses, we selected the diﬀerentially expressed genes
according to predeﬁned P value thresholds (0.05). The results
of diﬀerentially expressed genes were subjected to unsupervised hierarchical clustering (Cluster 3.0) and TreeView
analysis (Stanford University, Stanford, CA).
2.4. ceRNA Network Construction. A competing endogenous
RNA (ceRNA) network was constructed to discover the
ceRNA mechanism based on the diﬀerentially expressed
lncRNAs and miRNAs. RNA transcripts would combine
with miRNAs by miRNA response element (MRE), so we
could identify the competition relationship between RNA
transcripts in the process of combining MRE by predicting
MRE and computing free energy. First, in miRNA-mRNA
and miRNA-lncRNA, the target relationships were predicted
by target prediction database. Pearson’s correlation
coeﬃcient (PCC) between matched lncRNA-mRNA was
computed based on their expression data. Then, the PCC
between miRNA-mRNA and miRNA-lncRNA was computed. For a given lncRNA-mRNA pair, both mRNA and
lncRNA were targeted by a common miRNA and coexpressed negatively with this miRNA. Finally, this miRNAmRNA-lncRNA was identiﬁed as competing triplets.
2.5. Real-Time RT-PCR. Real-time RT-PCR veriﬁed the differential expression of 12 genes detected by the lncRNA/miRNA Expression Microarray. It also assessed the
lncRNA, miRNA, mCASP3, and mXIAP levels in AC16 cells.
NCode™ miRNA RT-qPCR System from Invitrogen is an
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example of a nondirect RT approach, requiring poly(A)-tailing of miRNAs prior to the RT reaction. NCode™ miRNA
First-Strand cDNA Synthesis Kits were used for polyadenylation and cDNA synthesis of miRNA. Then, amplify the
miRNA of interest using qPCR primers and DNA polymerase. Detection is through the binding of the SYBR® Green
dye to the ampliﬁed product. The PrimeScript™ RT Reagent
Kit with gDNA Eraser (Takara, Dalian, China) and genespeciﬁc primers or random primers were used to generate
cDNA of lncRNAs and mRNAs. Each real-time RT-PCR
reaction (in 20 μL) contained SYBR Green Real-Time PCR
Master Mix (TIAN-GEN), 0.5 μL primers, and 0.5 μL of template cDNA. Cycling conditions comprised of an initial,
single cycle of 2 minutes at 94°C, followed by 40 cycles of
15 seconds at 94°C, 20 seconds at 63°C, and 30 seconds at
68°C. PCR ampliﬁcations were performed in three duplicates
for each sample. Gene expression levels were quantiﬁed relative to the expression of 18S using an optimized comparative
Ct (DDCt) value method.
2.6. Lentivirus Vector Construction. The lentiviral vectors for
lentivirus-mediated upregulation and downregulation of
gene (lncRNA NONHSAT069381, lncRNA NONHSAT140844, hsa-miR-124-5p, and hsa-miR-6507-5p)
expression were purchased from Oligobiobio Co., Ltd.
(Beijing, China). To construct lentivirus-mediated overexpression of lncRNA/miRNA, the full-length coding
sequences of human lncRNA/miRNA C-terminally tagged
with GFP or GFP alone (control) were cloned into the lentivirus vector. Empty vector lentivirus served as negative
control (NC) (termed overexpression/knockdown control
in this study). To generate lentivirus-mediated overexpression vector, the expression sequence targeting human
lncRNA/miRNA was cloned into the lentivirus overexpression vector (termed overexpression in this study). Similarly,
to produce lentivirus-mediated silencing system targeting
human lncRNA/miRNA, a small interfering (5 ′ -gtcacagtccaacactgaggg-3 ′ ) sequence was cloned into the lentivirus
knockdown vector.
2.7. Cell Culture and Transfection. Human adult ventricular
cardiomyocyte cell line AC16 was obtained from the American Type Culture Collection (ATCC; Manassas, VA, USA).
Cells were cultured in Dulbecco’s modiﬁed Eagle’s medium
(DMEM; Invitrogen, Carlsbad, CA, USA) containing 10%
fetal bovine serum (FBS; HyClone, Logan, UT, USA) and
1% penicillin/streptomycin in a humidiﬁed incubator with
5% CO2 at 37°C. In this study, overexpression (lncRNA
NONHSAT069381, lncRNA NONHSAT140844, hsa-miR124-5p, and hsa-miR-6507-5p) and knockdown (lncRNA
NONHSAT069381, lncRNA NONHSAT140844, hsa-miR124-5p, and hsa-miR-6507-5p) and their control lentiviruses
were used to infect AC16 cells. Fluorescence microscopy
monitored infection eﬃciency after 48 hours postlentivirus
infection.
2.8. Western Blot. AC16 cells were homogenized in an icecold lysis buﬀer. After homogenization, the lysates were
centrifuged. The supernatant was saved and separated by
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electrophoresis on SDS-PAGE and transferred onto polyvinylidene diﬂuoride-plus membranes. After blocking buﬀer,
the immunoblots were probed with anti-total caspase 3 (Cell
Signaling) (lot: GR3356520-3), anti-XIAP (lot: GR32983104), and anti-actin (lot: GR333517-1) antibodies overnight at
4°C, followed by incubation with ﬂuorescent-conjugated secondary antibodies at room temperature for 1 hour.
2.9. H/R Model-Induced Cardiomyocyte Apoptosis
2.9.1. Establishing In Vitro Cardiomyocyte H/R Model. Seventy-two hours after AC16 cell transfection, all groups were
treated with hypoxia (95% N2 and 5% CO2) for 6 hours (via
Anaerobic Bag, Becton Dickinson and Inc., USA) and then
normoxia (74% N2, 21% O2, and 5% CO2) for 2 hours to simulate H/R.
2.10. TUNEL Staining. AC16 cells were cultured directly on
cover slips. TUNEL staining was performed per manufacturer’s instructions (In Situ Cell Death Protection Kit, Fluorescein, Roche, Indianapolis, IN). Total nuclei were stained
by DAPI (Vector Laboratories Inc., Burlingame, CA). Apoptotic index (i.e., the number of positively stained nuclei/
total number of nuclei counted × 100%) was determined in a
blinded manner.
2.11. Caspase Activity. After 2 hours of reoxygenation, AC16
cells were homogenized in an ice-cold lysis buﬀer for 30 seconds (PRO 200 homogenizer). Homogenates were centrifuged for 5 minutes at 10,000g at 4°C. Supernatants were
collected, and protein concentrations were measured using
the BCA method (Pierce Chemical, Rockford, IL). For each
well in a 96-well plate, the supernatant containing 200 mg
of protein was loaded and incubated with 25 mg AcDEVD-pNA, Ac-IETC-pNA, or Ac-LEHD-pNA at 37°C for
1.5 hours. pNA was cleaved from DEVD (by caspase-3,
BIOMOL), IETD (by caspase-8, BIOMOL), or LEHD (by
caspase-9, BIOMOL). Free pNA was quantiﬁed using a SpectraMax Plus microplate spectrophotometer (Molecular
Devices, Sunnyvale, CA) at 405 nm. Changes in caspase
activity in I/R tissue samples were calculated and expressed
as nmole pNA/mg/h [13].
2.12. Luciferase Reporter Assay. The ampliﬁed human 3 ′
-untranslated repeat segments of genes (lncRNA NONHSAT069381, lncRNA NONHSAT140844, CASP3, and
XIAP) containing the predicted hsa-miR-124-5p/hsa-miR6507-5p binding site were inserted into psiCHECK-2 vectors
containing Renilla luciferase (Promega) to generate the wild
plasmid (caspase-3 wt, XIAP wt, lncRNA NONHSAT069381
wt, and lncRNA NONHSAT140844 wt) or mutant plasmid
(caspase-3 mut, XIAP mut, lncRNA NONHSAT069381
mut, and lncRNA NONHSAT140844 mut) construct. For
luciferase assays, 239T cells were seeded in 96-well plates
and transfected with pLuc-3 ′ -untranslated repeat, 10 ng
Renilla, and the mimic/NC miRNA using Lipofectamine
2000 reagent (Invitrogen, Carlsbad, CA). Cells were collected
and analyzed using the Dual-Luciferase Reporter Assay System (Promega) after 48 hours. The luciferase activity values
were normalized relative to the Renilla luciferase internal
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Table 1: Clinical characteristics of volunteers.
Old (n = 19)

Young (n = 19)

P value

Age (y)

71:79 ± 6:40

19:89 ± 5:13

<0.001

Male (%)

100
24:57 ± 1:28

100
23:57 ± 1:18

0.016

0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0

n.s.
n.s.
n.s.
n.s.
n.s.
n.s.
n.s.
n.s.

0
0
0
0

0
0
0
0

n.s.
n.s.
n.s.
n.s.

General demographics

BMI (kg/m2)
Past medical history
Hypertension (%)
Lipid metabolic disorders (%)
Diabetes mellitus (%)
Coronary heart disease (%)
Heart failure (%)
Cancer (%)
Smoking (%)
Alcohol consumption (%)
Previous medication proﬁle
ACEI (%)
BB (%)
Statins (%)
CCB (%)

n.s.

Values are mean ± SD when appropriate. Abbreviations: BMI = body mass index; ACEI = angiotensin-converting enzyme inhibitor; BB = beta blocker;
CCB = calcium channel blocker; lipid metabolic disorders = LDL‐C > 3:0 mmol/L. P values determined by Student’s t-test or chi-square test.

control. Successful transfection of all cell treatment groups
was conﬁrmed prior to biological testing. Each experiment
was repeated three times in duplicate.
2.13. Statistical Analysis. The data was analyzed with Prism
5.0 (GraphPad Software, San Diego, CA, USA). All values in
the text and ﬁgures are presented as mean ± SD. Statistical differences were determined by Student’s t-test for comparison
between 2 groups and ANOVA followed by Bonferroni multiple comparison test for comparison among ≥3 groups. Probabilities of.05 or less were considered statistically signiﬁcant.

3. Results
3.1. lncRNA/miRNA Proﬁles in Human Blood Samples. 40
blood samples were initially taken. Two blood samples (one
old adult and one young) were excluded because of sample
contamination. 38 blood samples were used in the ﬁnal
results. In general, 19 pairs of older adult and young people
were healthy. Age and BMI were the major diﬀerences
between them (Table 1).
lncRNA/miRNA microarray was conducted in nineteen
pairs of human blood samples, with a total of 75,434
lncRNAs and 4012 miRNAs detected (Figures 1(a)–1(d)).
Among them, 2835 lncRNAs and 119 miRNAs were found
to be uniquely diﬀerent between older adult and young blood
samples. lncRNAs (NONHSAT069381 and NONHSAT140844) and miRNAs (hsa-miR-124-5p and hsamiR-6507-5p) increase signiﬁcantly with age (Figures 1(e)–
1(h)). Using ceRNA network analysis, we investigated the
relationship between aging-related lncRNAs and miRNAs
(Figures 1(i) and 1(j)).

3.2. Bioinformatics Analysis Suggests the Relationship between
lncRNAs, miRNAs, and mRNAs. The results of network analysis suggested that miRNAs may have synergistic eﬀects on
relative lncRNAs and mRNAs. We got all lncRNAs and miRNAs, which have signiﬁcant relationship with aging and
apoptotic factors. Within these RNAs, we selected 8 pairs of
lncRNAs and miRNAs (a lncRNA and a relative miRNA as
a pair) at random. The 8 pairs of RNAs met the following
inclusion criteria: (1) aging resulted in increasing >1.2 or
(2) aging resulted in decreasing <0.8. To conﬁrm the microarray results, the 8 pairs were subjected to real-time RT-PCR.
The results of real-time RT-PCR indicated that there are no
signiﬁcant aging-related diﬀerences in the 2 pairs. The
expression levels of the other 6 pairs of genes were consistent
with the microarray results (Figure 1(k)). Furthermore, the 6
pairs were subjected to functional experiments (apoptosis
regulation). The results of functional experiments demonstrated that signiﬁcant apoptosis-regulated eﬀects may exist
in the two groups of RNAs: (1) lncRNA NONHSAT069381,
hsa-miR-124-5p, and mCASP3 and (2) lncRNA NONHSAT140844, hsa-miR-6507-5p, and mXIAP (Figures 1(i)
and 1(j)). Functional experiments show that the remaining
four lncRNAs and four miRNAs have no functional eﬀects
on apoptosis.
3.3.
Gene
Manipulation,
Respectively,
Altered
NONHSAT069381 and NONHSAT140844 Expression in
AC16 Cells, Modifying CASP3 and XIAP Level and Activity.
To obtain direct evidence to support the relationship between
these molecules, cultured AC16 cells were divided into four
groups: (1) overexpression control (NONHSAT069381-overexpression control lentivirus), (2) overexpression
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Figure 1: The RNA expression proﬁles and bioinformatics analysis in older adult and young human blood samples. Heatmaps of total (a)
lncRNA and (b) miRNA from older adult and young human blood. Heatmaps demonstrate (c) lncRNA (NONHSAT069381 and
NONHSAT140844) and (d) miRNA (hsa-miR-124-5p and hsa-miR-6507-5p) proﬁles that diﬀerentiate older adult and young human
blood (each sample was assayed in triplicate). (e) NONHSAT069381, (f) NONHSAT140844, (g) hsa-miR-124-5p, and (h) hsa-miR-65075p expression is diﬀerent in older adult and young human blood. (i) Relationships between diﬀerent lncRNAs, miRNAs, and mRNAs. (j)
Magniﬁed (Figure 2(i)) portion. (k) Diﬀerent lncRNA and miRNA expressions conﬁrmed by RT-PCR. Diamond nodes represent mRNA,
box nodes represent lncRNA, and triangle nodes represent miRNA. ∗ P < 0:05 versus the young group.

(NONHSAT069381-overexpression lentivirus), (3) knockdown control (lncRNA NONHSAT069381 knockdown
control lentivirus), and (4) knockdown (lncRNA NONHSAT069381 knockdown lentivirus). Transfection eﬃcacy is
reported in Figure 2(a). No signiﬁcant eﬃcacy diﬀerence
existed among the four lentivirus-treated groups, but RTPCR results indicated that NONHSAT069381 levels increased
signiﬁcantly in AC16 cells subjected to overexpressionencoding lentivirus treatment (Figure 2(c)). Conversely, the
levels of NONHSAT069381 were signiﬁcantly reduced in
AC16 cells subjected to knockdown-encoding lentiviruses
(Figure 2(d)). We analyzed the inﬂuence of lncRNA expression changes on related mRNAs in AC16 cells using Western
blot. The results demonstrated that increased NONHSAT069381 levels resulted in signiﬁcantly increased CASP3
levels and activity. Decreased NONHSAT069381 levels
resulted in signiﬁcantly decreased CASP3 level and activity
(Figures 2(e) and 2(f)).
Cultured AC16 cells were divided into four groups: (1)
overexpression control (NONHSAT140844-overexpression
control lentivirus), (2) overexpression (NONHSAT140844overexpression lentivirus), (3) knockdown control (lncRNA
NONHSAT140844 knockdown control lentivirus), and (4)
knockdown (lncRNA NONHSAT140844 knockdown lentivirus). Transfection eﬃcacy is reported in Figure 2(b). We
also explored the relationship between NONHSAT140844
and XIAP in the same way. The results showed that increased
levels of NONHSAT140844 led to signiﬁcantly increased
XIAP level and activity. Decreased levels of NONHSAT140844 led to signiﬁcantly decreased XIAP level and
activity (Figures 2(g)–2(j)).

3.4. Gene Manipulation of NONHSAT069381 and
NONHSAT140844, Modifying H/R-Induced Apoptosis in
AC16 Cells. lncRNA (NONHSAT069381 and NONHSAT140844) expression was upregulated or downregulated
by lentiviral vectors. The eﬀects of gene manipulation upon
AC16 cell apoptosis were assessed using TUNEL staining
and caspase activity measurement.
Compared with the control, a signiﬁcant increment of
total TUNEL-positive nuclei was observed in the NONHSAT069381 overexpression group (Figures 3(a) and 3(c))
and NONHSAT069381 downregulation decreased the H/Rinduced cardiomyocyte apoptotic ratio (Figures 3(a) and
3(c)). The activities of caspase-3, caspase-8, and caspase-9
were determined as well. After H/R injury, compared with
the control, the activities of three caspases in the NONHSAT069381 overexpression group were signiﬁcantly
increased, while the activities of three caspases in the NONHSAT069381 knockdown group were signiﬁcantly decreased
(Figures 3(d)–3(f)).
The results of the NONHSAT140844 group are the opposite. Compared to the control, the total TUNEL-positive
nucleus of the NONHSAT140844 overexpression group
was signiﬁcantly reduced (Figures 3(b) and 3(g)) and downregulation of NONHSAT140844 increased the H/R-induced
cardiomyocyte apoptotic ratio (Figures 3(b) and 3(g)). Moreover, the activities of three caspases were signiﬁcantly
decreased in the NONHSAT140844 overexpression group,
while the activities of three caspases were signiﬁcantly
increased in the NONHSAT140844 knockdown group compared to the control after H/R injury (Figures 3(h)–3(j)). In
summary, these results suggest that aging may regulate
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Figure 2: Gene transfection of lncRNA (NONHSAT069381 and NONHSAT140844) and altered resultant caspase-3 and XIAP activity.
Transfection eﬃciency, 48 hours after lncRNA (a) NONHSAT069381 and (b) NONHSAT140844 overexpression (OE-069381/OE140844) or knockdown (KD-069381/KD-140844) by lentiviral transfection of AC16 cells. Transfection eﬃciency indicated by concomitant
contrast and ﬂuorescence microscopy. Lentiviral vectors carried GFP gene. AC16 cells infected by lncRNA
NONHSAT069381/NONHSAT140844-carrying lentivirus are identiﬁable by ﬂuorescence microscopy 48 hours after infection. (c, d) The
relative expression of NONHSAT069381 was measured by RT-PCR. (e, f) Representative immunoblots of caspase-3 from
NONHSAT069381 overexpression or knockdown in AC16 cells. (g, h) The relative expression of NONHSAT140844 was measured by
RT-PCR. (i, j) Representative immunoblots of XIAP from NONHSAT140844 overexpression or knockdown in AC16 cells. n = 6.
∗
P < 0:05 versus overexpression/knockdown control (OE-Ctrl/KD-Ctrl).

post-H/R apoptosis via NONHSAT069381-CASP3 (increase)
and NONHSAT140844-XIAP (decrease) pathway signaling.
3.5. lncRNA NONHSAT069381 Played a ceRNA Role in
Regulating CASP3 Expression by Binding to hsa-miR-124-5p
and lncRNA NONHSAT140844 Played a ceRNA Role in
Regulating XIAP Expression by Binding to hsa-miR-6507-5p.
Further prediction of target genes of miRNA was performed
by TargetScan (http://www.targetscan.org/vert_71/) and
Miranda
(http://www.microrna.org/microrna/home.do).
We then conducted a luciferase reporter assay to validate
the binding of miRNA (hsa-miR-124-5p, hsa-miR-65075p), lncRNA (NONHSAT069381, NONHSAT140844), and
mRNA (CASP3, XIAP). hsa-miR-124-5p transfection significantly inhibited NONHSAT069381 and CASP3 luciferase
activity (Figures 4(a) and 4(b)), while hsa-miR-6507-5p
transfection signiﬁcantly inhibited NONHSAT140844 and
XIAP luciferase activity in 293T cells (Figures 4(c) and 4(d)).

Cultured AC16 cells were divided into four groups: (1)
overexpression control (hsa-miR-124-5p-overexpression
control lentivirus), (2) overexpression (hsa-miR-124-5poverexpression lentivirus), (3) knockdown control (hsamiR-124-5p knockdown control lentivirus), and (4) knockdown (hsa-miR-124-5p knockdown lentivirus). Firstly, no
signiﬁcant eﬃcacy diﬀerence existed among the four
lentivirus-treated groups, but RT-PCR results indicated that
hsa-miR-124-5p levels increased signiﬁcantly in AC16 cells
subjected to overexpression-encoding lentivirus treatment
(Figure 5(a)). Conversely, the levels of hsa-miR-124-5p
decreased signiﬁcantly in AC16 cells subjected to
knockdown-encoding lentiviruses (Figure 5(a)). We used
RT-PCR to assess the RNA expression of mCASP3 in AC16
cells overexpressed or knockdown hsa-miR-124-5p. The
results indicated that increased hsa-miR-124-5p levels
resulted in signiﬁcantly decreased CASP3 activity, while
decreased hsa-miR-124-5p levels resulted in signiﬁcantly
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Figure 3: Genetic manipulation of NONHSAT069381 and NONHSAT140844 alters AC16 cell apoptosis after H/R. (a, b) Representative
photomicrographs of in situ detection of cardiomyocyte DNA fragments subjected to H/R. Cardiomyocytes were stained with TUNEL
(red) and DAPI (blue). TUNEL-positive nuclei of the NONHSAT069381 group were summarized in graph and expressed as percentage of
all cardiomyocytes subjected to H/R (c). Cardiomyocyte caspase-3, caspase-8, and caspase-9 activity of the NONHSAT069381 group was
measured after H/R (d–f). TUNEL-positive nuclei and cardiomyocyte caspase-3, caspase-8, and caspase-9 activity of the
NONHSAT140844 group (g–j). n = 12 plates/group. ∗ P < 0:05 versus overexpression/knockdown control.

increased CASP3 activity (Figure 5(b)). The results of the
Western blot were consistent with RT-PCR (Figures 5(c)
and 5(d)). Moreover, we measured the eﬀects of hsa-miR124-5p overexpression and knockdown on NONHSAT069381 level. The results indicated whether overexpression or knockdown of hsa-miR-124-5p did not aﬀect
the level of NONHSAT069381 signiﬁcantly (Figure 5(e)).
Furthermore, cultured AC16 cells were divided into four
groups: (1) overexpression control (hsa-miR-6507-5p-overexpression control lentivirus), (2) overexpression (hsa-miR6507-5p-overexpression lentivirus), (3) knockdown control
(hsa-miR-6507-5p knockdown control lentivirus), and (4)
knockdown (hsa-miR-6507-5p knockdown lentivirus). The
results of the hsa-miR-6507-5p group indicated that
increased levels of hsa-miR-6507-5p led to a signiﬁcantly
decreased XIAP activity, and decreased levels of hsa-miR6507-5p led to a signiﬁcant increment in XIAP activity
(Figures 5(f)–5(i)). Similarly, the overexpression and knockdown of hsa-miR-6507-5p did not change the level of NONHSAT140844 in AC16 cells (Figure 5(j)). In summary, these
results are consistent with and support the bioinformatics
analysis ﬁndings.

4. Discussion
The increased mortality rate in the geriatric population
related to cardiovascular disease suggests that cardiac aging
itself may be a major risk factor for cardiovascular pathologies such as ischemic heart disease. However, the potential
mechanisms were unclear. Apoptosis is a well-established cell
death process after I/R injury. Previously, we demonstrated
that cardiomyocyte apoptosis increases after ischemiareperfusion and apoptosis contributes to heart failure [4, 7].
Our present study showed that lncRNAs (NONHSAT069381 and NONHSAT140844) were increased in
aging human blood, conﬁrmed by both bioinformatics analysis and PCR. However, the precise roles that lncRNAs in
aging-related cardiomyocyte apoptosis play in humans
remain uncertain. Therefore, we further veriﬁed their role
by utilizing cardiomyocyte lines (AC16 cells) and found that
lncRNAs act as ceRNAs in the eﬀects of aging-related cardiomyocyte apoptosis.
There have been some novel ﬁndings in our present
study. First, our results indicated that lncRNAs played vital
roles in hypoxia-induced myocardial apoptosis in the human
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Figure 4: The miRNA-targeted mRNAs and lncRNA were validated by luciferase reporter assay. (a) Luciferase reporter assay performed by
cotransfection of lncRNA NONHSAT069381 and luciferase reporter containing the wild or mutant 3 ′ -UTR of lncRNA NONHSAT069381
with hsa-miR-124-5p mimic or NC in 293T cells. (b) Luciferase reporter assay performed by cotransfection of luciferase reporter containing
wild or mutant 3 ′ -untranslated repeat (UTR) of mCASP3 with hsa-miR-124-5p mimics or negative control in 239T cells. (c) Luciferase
reporter assay performed by cotransfection of lncRNA NONHSAT140844 and luciferase reporter containing the wild or mutant 3 ′ -UTR of
lncRNA NONHSAT140844 with hsa-miR-6507-5p mimic or negative control in 293T cells. (d) Luciferase reporter assay performed by
cotransfection of luciferase reporter containing wild or mutant 3 ′ -untranslated repeat (UTR) of mXIAP with hsa-miR-6507-5p mimics or
negative control in 239T cells. Luciferase activity was determined 48 hours after cotransfection. n = 6. ∗ P < 0:05 versus mimic negative control.

cardiomyocyte line. Second, we found that in addition to proapoptotic eﬀects, lncRNAs also decreased the occurrence of
myocardial apoptosis via antiapoptotic factors. We identiﬁed
NONHSAT069381 and NONHSAT140844 as lncRNAs regulating apoptosis. Overexpression of NONHSAT069381 or
knockdown of NONHSAT140844 augmented the myocardial
apoptotic ratio after H/R, whereas overexpression of NONHSAT140844 or knockdown of NONHSAT069381 decreased
the apoptotic ratio of cardiomyocytes. Lastly, we proved that
lncRNA NONHSAT069381 played a ceRNA role in regulating
mCASP3 expression by binding to hsa-miR-124-5p, while
lncRNA NONHSAT140844 played a ceRNA role in regulating
XIAP expression by binding to hsa-miR-6507-5p.
The Encyclopedia of DNA Elements (ENCODE) Project
Consortium indicated that more than 28,000 lncRNAs were
transcribed in the whole human genome [14]. The functions
of most lncRNAs remain unidentiﬁed. Furthermore, almost
all studies related to lncRNAs and cardiomyocyte apoptosis,
including our previous studies, have been performed
in vitro or in animal models. The characteristics of lncRNAs

in humans/the human cardiomyocyte line with respect to
aging-related apoptosis remain unknown. To our knowledge,
this is the ﬁrst time lncRNA NONHSAT069381 and NONHSAT140844 have been correlated with aging and apoptosis
in the human cardiomyocyte line.
Caspases are the key eﬀector molecules of apoptosis.
Sequential activation of caspases plays a central role in the
execution phase of cell apoptosis [15]. Previous studies have
shown that proapoptotic members of caspase-8 were
regarded as the initiators of apoptosis and caspase-3 was
the executor and terminator of multiple apoptotic pathways
[16–19]. Among the human inhibitors of apoptosis proteins
(IAPs), X-chromosome-linked IAP (XIAP) is the most studied [20]. In apoptotic signaling, XIAP binds to caspase-3, caspase-7, and caspase-8 by locating a linker region [21, 22].
XIAP therefore serves as a repressor and regulator of the ﬁnal
steps of apoptotic signaling, acting mostly at the level of
activation of executioner caspases. The present study suggests that augmentation of NONHSAT069381 increased
downstream CASP3 activity and augmentation of
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Figure 5: Gene transfection of miRNA (hsa-miR-124-5p and hsa-miR-6507-5p) and altered resultant caspase-3 and XIAP activity. (a) The
relative expression of hsa-miR-124-5p was measured by RT-PCR. (b) The relative expression of mCASP3 from hsa-miR-124-5p
overexpression (OE-hsa-miR-124-5p) or knockdown (KD-hsa-miR-124-5p) in AC16 cells conﬁrmed by RT-PCR. (c, d) Representative
immunoblots of caspase-3 from hsa-miR-124-5p overexpression or knockdown in AC16 cells. (e) The relative expression of
NONHSAT069381 from hsa-miR-124-5p overexpression or knockdown in AC16 cells conﬁrmed by RT-PCR. (f) The relative expression
of hsa-miR-6507-5p was measured by RT-PCR. (g) The relative expression of mXIAP from hsa-miR-6507-5p overexpression (OE-hsamiR-6507-5p) or knockdown (KD-hsa-miR-6507-5p) in AC16 cells conﬁrmed by RT-PCR. (h, i) Representative immunoblots of XIAP
from hsa-miR-6507-5p overexpression or knockdown in AC16 cells. (j) The relative expression of NONHSAT140844 from hsa-miR-65075p overexpression or knockdown in AC16 cells conﬁrmed by RT-PCR. n = 6. ∗ P < 0:05 versus overexpression/knockdown control.

NONHSAT140844 increased downstream XIAP activity.
Our results indicate that in addition to apoptosispromoting eﬀects, lncRNAs also inhibited the occurrence of
myocardial apoptosis via apoptosis-inhibiting factors. It suggests that aging exacerbated the bidirectional regulatory
eﬀects on myocardial apoptosis, which could both promote
and retard apoptosis, ultimately maintaining the balance
between proapoptosis and antiapoptosis.
Additionally, increasing experimental evidence supports
that lncRNA functions as competitive endogenous RNA
(ceRNA), which compete for miRNA to upregulate the
expression of a target gene [23]. The ceRNA hypothesis
may provide new insights into the function of a large amount
of uncharacterized lncRNAs. The present study suggests that
both NONHSAT069381 and CASP3 interact with hsa-miR124-5p, suggesting that NONHSAT069381 regulates CASP3
expression by competing to bind to hsa-miR-124-5p. It is the

same in regard to NONHSAT140844. NONHSAT140844
regulates the expression of XIAP by competing to bind to
hsa-miR-6507-5p.
Almost all age-related apoptosis studies, including our
previous study, demonstrated aging augmented postischemia
apoptosis. However, our previous data suggests that aging
may also reduce apoptosis through lncRNA, an unknown
pathway in mouse cardiomyocytes. The present study conﬁrmed that in addition to apoptosis-promoting eﬀects, aging
also inhibits cardiomyocyte apoptosis after H/R. It is the ﬁrst
report to our knowledge of an age-mediated antiapoptotic
cardiac eﬀect in the human cardiomyocyte line.

5. Conclusion
In summary, we have provided evidence that lncRNA may
both promote and inhibit cardiomyocyte apoptosis after
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hypoxia or ischemia. NONHSAT069381/hsa-miR-1245p/CASP3 and NONHSAT140844/hsa-miR-6507-5p/XIAP
may be important regulatory axes in aging-mediated eﬀects
upon apoptosis. In addition, the apoptosis regulatory eﬀects
of aging are complex. The high burden of comorbidities is
also an important factor in the clinical setting.
5.1. Limitation. This study is aimed at elucidating the
changes of lncRNA and miRNA in cardiomyocytes after
aging and their potential regulatory functions in apoptosis.
Through the above experiments, we can clarify the relationship between human aging and myocardial apoptosis. However, it is diﬃcult to obtain human myocardium of diﬀerent
ages. Therefore, we innovatively employed a “bridge” study
model to ﬁnd aging-related lncRNA and miRNA in human
blood and then verify the apoptosis-regulating function of
aging-related lncRNA and miRNA in human cardiomyocyte
cell lines. In addition, BMI was diﬀerent between the older
adult group and the young group. However, the size of diﬀerence seems clinically irrelevant. Although the above methods
cannot fully conﬁrm the eﬀect of human aging on cardiomyocyte apoptosis, it indirectly reﬂects the regulatory eﬀect
of human myocardial aging on apoptosis.
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